MHRA approves Retifanlimab (ZYNYZ) for the treatment of advanced Merkel cell skin cancer
seen at 11:45, 6 July in News and communications.MHRA approves Retifanlimab (ZYNYZ) for the treatment of advanced Merkel cell skin cancer
seen at 11:45, 6 July in News and communications.